Piper Sandler raised the firm’s price target on Westlake to $180 from $160 and keeps an Overweight rating on the shares to reflect the data from the Q1 earnings release, Q2 guidance and recent channel checks. The firm has reduced both its 2024 and 2025 EBITDA estimates but remains well above Street consensus for both years.